Clinical Trials Browser

Phase EARLY_PHASE1 × Colonic Neoplasms × Cetuximab × Clear all

NCT06011772 2026-03-11

EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Colonic Neoplasms

NCT00835679 2014-05-23

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

Phase EARLY_PHASE1 Terminated

9 enrolled 3 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms